Diabesity: Confronting the Dual Epidemic of Diabetes and Obesity

This session will delve into the intersection of obesity and type 2 diabetes.  Learners will explore strategies for glycemic and weight management, cardiorenal protection, and cardiovascular risk mitigation, with an emphasis on the latest guidelines for managing type 2 diabetes and providing holistic care.

Learning Objectives

  • Examine the relationship between type 2 diabetes mellitus (T2DM) and obesity and the therapeutic benefits of sustained weight loss on the long-term health risks of both conditions
  • Discuss a holistic integrated approach to the management of T2DM, obesity, and other comorbid conditions
  • Consider recent guideline recommendations for T2DM management, which stratify therapies according to their likelihood of achieving both glycemic and weight loss goals 
  • Examine the evidence for glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose cotransporter-2 (SGLT2) inhibitors for cardiorenal protection in T2DM and obesity 

Additional Information

Partner: 
Pri-Med Institute
Course summary
Available credit: 
  • 1.00 AANP Contact Hours
  • 0.25 AANP Pharmacology Contact Hours
  • 1.00 AMA PRA Category 1 Credit™
Course opens: 
03/20/2024
Course expires: 
05/30/2024
Rating: 
0

Charles Vega, MD, FAAFP

Health Sciences Clinical Professor
Assistant Dean for Culture & Community Education
Executive Director, UC Irvine Program in Medical Education for the Latino Community UC Irvine School of Medicine
Irvine, CA

Disclosures

The following relevant financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute.

Charles Vega, MD, FAAFP: Consultant for Boehringer Ingelheim.
Ty Gluckman, MD, MHA (Moderator): Consultant for Premier and OptumRx 

Non-faculty contributors and others involved in the planning, development, editing, and review of the content have disclosed no relevant financial relationships.

Accreditation Statement

Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

Pri-Med Institute designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AANP

Accreditation Statement

Pri-Med Institute is accredited by the American Association of Nurse Practitioners® as an approved provider of nurse practitioner continuing education. Provider number: 040308. 

Designation Statement

This activity is approved for 1.0 contact hour of continuing education, which includes 0.25 hours of pharmacology.

MOC Credit Information

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 

Available Credit

  • 1.00 AANP Contact Hours
  • 0.25 AANP Pharmacology Contact Hours
  • 1.00 AMA PRA Category 1 Credit™
Please login or register to take this course.

This course is offered through Pri-Med. 

 

To take this course you will be redirected to Pri-Med's website. You must login or create an account with Pri-Med in order to complete this activity. 

 

Mocingbird works to provide curated, high quality content to our users. Have a suggestion? Want to partner with us? Get in touch!